Pharmacoeconomy of drugs used in the treatment of actinic keratoses.

Nisticò, S; Torchia, V; Gliozzi, M; Bottoni, U; Del Duca, E; Muscoli, C

Nisticò, S; Torchia, V; Gliozzi, M; Bottoni, U; Del Duca, E; Muscoli, C.

Affiliation

Nisticò S; Department of Health Sciences, University of Catanzaro "Magna Graecia", Italy steven.nistico@gmail.com.
Torchia V; Interregional Research Center for Food Safety & Health, Department of Health Sciences, University of Catanzaro "Magna Graecia", Italy.
Gliozzi M; Interregional Research Center for Food Safety & Health, Department of Health Sciences, University of Catanzaro "Magna Graecia", Italy.
Bottoni U; Department of Health Sciences, University of Catanzaro "Magna Graecia", Italy.
Del Duca E; Department of Health Sciences, University of Catanzaro "Magna Graecia", Italy.
Muscoli C; School of Pharmacy and Nutraceuticals, University of Catanzaro "Magna Graecia", Italy.

Int J Immunopathol Pharmacol ; 29(4): 796-804, 2016 Dec.

Article in En | MEDLINE | ID: mdl-27207444

Subject(s)

Diclofenac/therapeutic use; Diterpenes/therapeutic use; Keratosis, Actinic/drug therapy; Cost-Benefit Analysis; Humans; Italy; Quality of Life; Treatment Outcome

Key words

actinic keratosis; cost-efficacy analysis; diclofenac sodium; ingenol mebutate

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diclofenac / Diterpenes / Keratosis, Actinic Limits: Humans Country/Region as subject: Europa Language: En Journal: Int J Immunopathol Pharmacol Journal subject: ALERGIA E IMUNOLOGIA / FARMACOLOGIA / PATOLOGIA Year: 2016 Type: Article Affiliation country: Italy

Fulltext

XML

PubMed Links

Search on Google